openPR Logo
Press release

Bioengineered Protein Drugs Market by Drug Type, Disease Condition, End Users & Forecast - 2025 | TMR

05-25-2020 05:09 PM CET | Health & Medicine

Press release from: Transparency Market Research

Bioengineered Protein Drugs Market - Snapshot

Bioengineering is the application of engineering technology and methods to the field of biology. Polymer of amino acids, proteins play a significant role in facilitating smooth functioning of the human body. With the utilization of genetic engineering procedure, bioengineered proteins are synthesized. These proteins are also known as recombinant protein, which is used in the treatment of many illnesses. Wide scope of application is likely to bolster the growth of the global bioengineered protein drugs market. Bioengineered protein drugs are utilized in the treatment of various chronic conditions such as

Diabetes
Asthma
Cancer
Blood disorders
Fertility disorders
Immunological disorders
Hormonal disorders
Bioengineered protein drugs are considered extremely efficient with much improved pharmacodynamic (PD) and Pharmacokinetic (PK) characteristics. These drugs come with better matching with biological processes and thus have minimum side effects and wider acceptance. This factor is likely to drive the growth of the global bioengineered protein drugs market in the years to come.

Request Sample Of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8188

Advancement in the Biopharmaceutical Field to Stoke Demand in the Market

The global bioengineered protein drugs market is also likely to be driven by the immense technological and research-based progress made in the biopharmaceuticals field. In addition, a rise in the prevalence of chronic diseases is estimated to drive the demand for bioengineered protein drugs.

The drugs fare better than small molecule drugs in terms of the time taken for receiving approval from FDA. Bioengineered protein drugs takes much less time, which is a significant factor in driving the market over the tenure of assessment. In accordance with the findings of world health organization (WHO), it is estimated that the number of people suffering from diabetes with rise to 36 million by 2030. However, complication is involved in the treatment of diseases utilizing bioengineered protein drugs is likely to restrain the growth of the global bioengineered protein drugs market. Furthermore, the rising cost of these drugs is predicted to come up as another factor hampering development of the market in near future.

Global Bioengineered Protein Drugs Market: Snapshot

Majorly fuelling the global bioengineered protein drugs market is the rising occurrence of infectious diseases, diabetes, cancer, etc. This is because bioengineered protein drugs are more effective and additionally have reduced or no side effects when compared with alternative therapies for cancer, diabetes, and other maladies. This has led to more healthcare physicians prescribing these drugs, thereby stoking demand in the market.

The prospects in the global market for bioengineered protein drugs also looks upbeat owing to increasing drugs in phase III of clinical trials and many companies pouring money into research and development of novel bioengineered proteins.

Posing a roadblock to the market, on the other hand, is the steep cost of manufacturing bioengineered protein drug, having shorter shelf life. The emergence of biosimilars is also posing a severe challenge to the growth in the market.

A report by Transparency Market Research predicts the global bioengineered protein drugs market to expand at a 7.4% CAGR from 2017 to 2024 to become worth US$336.9 bn by 2025 from US$177.7 bn in 2016.

Request the Coronavirus Impact Analysis on this Markets - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=8188

global bioengineered protein drugs market
Vaccines Slated to Grow at Maximum Pace due to Development of Bioengineered Prophylactic Vaccines

The global bioengineered protein drugs market can be classified into monoclonal antibodies, vaccines, and therapeutic protein based upon the type of product. The therapeutic protein segment, among them, accounts for a dominant share because of extensive activities in the therapeutic protein engineering and recombinant DNA technology products. In terms of growth rate, however, the vaccines segment is expected to outshine all other segments by clocking maximum CAGR between 2017 to 2025 because of increase in development of bioengineered prophylactic and therapeutics vaccines.

Rising Instances of Cancer Propels North America Market to Fore

From a geographical standpoint, North America leads the global bioengineered protein drugs market. In the years ahead, the region is slated is maintain its dominant position because of the rising occurrence of cancer and unveiling of innovative protein therapeutics for cancer. While loss of patents of blockbuster drugs such as Humira, Rituxan, Avastin, and Remicade, among others, are expected to deal a blow to the revenue in the market, launch of new drugs and approvals for new diagnostic tests, along with a growing geriatric population and unhealthy lifestyle will likely make up for it by inducing growth. As per the TMR report, the bioengineered protein drugs market in North America will likely register a CAGR of 7.2% from 2017 to 2025 to become worth US$161.05 bn by 2025.

More Trending Reports by Transparency Market Research - https://www.biospace.com/article/pharmacy-automation-systems-market-competitive-landscape-and-geographical-outlook/

Contact

Transparency Market Research,

90 Sate Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants uses proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bioengineered Protein Drugs Market by Drug Type, Disease Condition, End Users & Forecast - 2025 | TMR here

News-ID: 2056913 • Views: 116

More Releases from Transparency Market Research

Fuel Dispenser Market - Global Industry Analysis, Size, Share, Growth, Trends, a …
Albany, NY - Fuel Dispenser Market: Introduction In terms of value, the global fuel dispenser market is expected to reach ~US$ 2 Bn by 2030, expanding at a CAGR of ~4% during the forecast period. Based on volume, the global fuel dispenser market is estimated to reach 662,058 units by 2030, expanding at a CAGR of ~4% during the forecast period. In terms of type, the submersible system segment holds leading
Brazil Flavored and Functional Water Market Outlook, Gains Traction, Analysis An …
According to the report, the market will exhibit an impressive CAGR of 7.3% during the projection period. With this rate of growth, by the end of 2024, the market will be valued around US$9.4 bn. It is a considerable growth from the initial valuation recorded at US$5 bn in 2015. A new report by Transparency Market Research expects the Brazil flavored functional water market to grow at considerable pace over
Advantame Market Trends , Incredible Growth Opportunities, Volume, Value Growth …
Increasing health issues among the population led to an increase in the demand for non-caloric sweetener. In the global food and beverage market, the demand for advantame is on rising owing to its non-caloric sweetener properties. Advantame is one of the most recent, high potency low-calorie sweeteners to arrive in the food and beverage market with clean sugar-like the taste. The rising consumption of unhealthy/ comfort sugary food with high calories
Trends in the Feed ingredients - Outlook, Share and Opportunities in Grooming Re …
Escalating demand for high nutritional value meat is one of the major factor driving the growth of global feed ingredients market. In the global meat products market, safety is one of the major concern among meat manufacturers owing to stringent rules laid by government organizations during the handling, procurement, processing, storage, and distribution of animal products. The inclusion of high nutritive value feed ingredient into animal feed results in more

All 5 Releases


More Releases for Bioengineered

Bioengineered Protein Drugs Market Growth and Sales Forecast 2017 - 2015
As per a report by Transparency Market Research, the global bioengineered protein drugs market will rise at a 7.4% CAGR during the period between 2017 and 2024 to become worth US$336.9 bn by 2025 from US$177.7 bn in 2016. Emergence of Innovative Protein Therapeutics Slated to Boost North America Market Depending upon the type of product, the global bioengineered protein drugs market can be classified into monoclonal antibodies, vaccines, and therapeutic protein.
Bioengineered Proteins Drugs Market to Discern Magnified Growth by 2022
Qyresearchreports include new market research report Global Bioengineered Proteins Drugs Market Size, Status and Forecast 2022 to its huge collection of research reports. The overall market for Bioengineered Proteins Drugs has been inspected on a few flow that have formally influenced the improvement of the market in a few ways. The report furthermore voices unmistakable experiences and data identifying with the overall Bioengineered Proteins Drugs market. The inside purpose of the
Bioengineered Protein Drugs Market to Develop Rapidly by 2025
As per a report by Transparency Market Research, the global bioengineered protein drugs market will rise at a 7.4% CAGR during the period between 2017 and 2024 to become worth US$336.9 bn by 2025 from US$177.7 bn in 2016. Emergence of Innovative Protein Therapeutics Slated to Boost North America Market Depending upon the type of product, the global bioengineered protein drugs market can be classified into monoclonal antibodies, vaccines, and therapeutic protein.
Bioengineered Protein Drugs Market Report 2017
Reports And Markets Publish a New Market Research Report On –"Bioengineered Protein Drugs Market Report 2017" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/asia-pacific-bioengineered-protein-drugs-market-report-2017-1541146 In this report, the Asia-Pacific Bioengineered Protein Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key
Bioengineered Protein Drugs Market Research Report Forecast to 2025
Majorly fuelling the global bioengineered protein drugs market is the rising occurrence of infectious diseases, diabetes, cancer, etc. This is because bioengineered protein drugs are more effective and additionally have reduced or no side effects when compared with alternative therapies for cancer, diabetes, and other maladies. This has led to more healthcare physicians prescribing these drugs, thereby stoking demand in the market. The prospects in the global market for bioengineered protein
Bioengineered Proteins Drugs Market: Technologies, Markets and Players
Some of the major companies operating in the global bio-engineered protein drugs market areAllergan, AbbVie, Inc., Agilent Technologies,Eli Lilly and Company, F. Hoffmann-La Roche AG, Pfizer Inc.,GlaxoSmithKline plc, Novartis AG, Panacea Biotec Ltd., Sanofi S.A, Wockhardt Ltd. Bio engineered proteins drugs are synthesized through genetic engineering for treatment of human injury, systemic treatments of cancers, organ transplants etc. They are also known as Recombinant Protein drugsand are used for modification